Jefferies on Globus Medical (GMED) Warning Letter: 'Not Expected to Have any Material Impact; No Change to Sales Expects; Buy'
Tweet Send to a Friend
Jefferies analyst Matthew Taylor reiterated a Buy rating and $85.00 price target on Globus Medical (NYSE: GMED)The analyst comments "GMED ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
